Michael Logerfo, Chief Legal Officer at Sagent Pharmaceuticals, Inc. (SGNT), bought 2,000 shares at $15.69 ($31K) on 2012-05-17, disclosed to the SEC on 2012-05-18.
Open-market purchase of $31k SGNT by Chief Legal Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SGNT | SELL | 2012-11-20 | $134K | — | Filing → |
| SGNT | SELL | 2012-11-16 | $144K | — | Filing → |
| SGNT | SELL | 2012-05-29 | $111K | — | Filing → |